Due to the majority of currently available genome data deriving from individuals of
European ancestry, the clinical interpretation of genomic variants in individuals from
diverse ethnic backgrounds remains a major diagnostic challenge. Here, we investi-
gated the genetic cause of a complex neurodevelopmental phenotype in two Pales-
tinian siblings. Whole exome sequencing identified a homozygous missense TECPR2
variant (Chr14(GRCh38):g.102425085G>A; NM_014844.5:c.745G>A, p.(Gly249Arg))
absent in gnomAD, segregating appropriately with the inheritance pattern in the fam-
ily. Variant assessment with in silico pathogenicity prediction and protein modeling
tools alongside population database frequencies led to classification as a variant of
uncertain significance. As pathogenic TECPR2 variants are associated with hereditary
sensory and autonomic neuropathy with intellectual disability, we reviewed previ-
ously published candidate TECPR2 missense variants to clarify clinical outcomes and
variant classification using current approved guidelines, classifying a number of pub-
lished variants as of uncertain significance. This work highlights genomic healthcare
inequalities and the challenges in interpreting rare genetic variants in populations
underrepresented in genomic databases. It also improves understanding of the clinical
and genetic spectrum of TECPR2-related neuropathy and contributes to addressin